Compounds of formula (I): 1
wherein:
R.sup.1 represents an optionally substituted heteroaryl group,
R.sup.2 represents an optionally substituted cycloalkyl group,
R.sup.3 represents a hydrogen atom or an alkyl group, and
R.sup.4 and R.sup.5 are as defined in the description, and
Medicinal products containing the same are useful in the treatment of
non-insulin-dependent type II diabetes, obesity, type I diabetes,
hyperlipidaemia, hypercholesterolaemia and cardiovascular complications
thereof.
